jueves, 26 de noviembre de 2009

Vitespen - European Medicines Agency - Withdrawals of Application - Medicinal Products for Human Use - Oncophage


Withdrawals of Application - Medicinal Products for Human Use
Oncophage [Vitespen]
Withdrawal EPAR


The European Medicines Agency has been formally notified by Antigenics Therapeutics Limited of its decision to withdraw its application for a centralised marketing authorisation for the medicine Oncophage (vitespen), 20 μg solution for infusion.

abrir aquí para acceder al documento EMEA completo:
European Medicines Agency - Withdrawals of Application - Medicinal Products for Human Use - Oncophage
file3848month480

No hay comentarios:

Publicar un comentario